Traditional medicine treatment of reflux esophagitis can only control superficial symptoms and needs long-term medication maintenance. Once the drug is stopped, it is easy to relapse, so it is particularly important to find new treatment methods. Especially for patients with serious illness, they want to get rid of the pain of taking medicine for a long time while relieving symptoms.
A "new concept" for the treatment of reflux esophagitis: standard treatment
The treatment goal is a static and fixed goal, but the standard treatment is different from the treatment goal, and it is a dynamic and approaching process. First of all, we should make a treatment goal according to the characteristics of the disease and the needs of patients. Then, in the process of consultation, it is necessary to monitor whether the treatment goal is achieved. At the same time, the treatment plan is constantly adjusted according to the monitoring situation until the treatment reaches the standard. Standardized treatment is a long-term management of diseases, which can effectively reduce complications and improve the condition.
What is the goal of standard treatment for reflux esophagitis?
The "new" concept of treating reflux esophagitis is the same as diabetes. Diabetes achieves the target level by glycosylating hemoglobin, thus controlling blood sugar for a long time and reducing complications. The "new" concept of reflux esophagitis treatment is that the clinical goal of standardized treatment is to achieve mucosal healing, so as to achieve the effect of symptom relief and disease recovery.
Why should the treatment of reflux esophagitis achieve mucosal healing?
The more serious the mucosal erosion in patients with reflux esophagitis, the higher the probability of complications such as ulcer and bleeding. Moreover, mucosal erosion is too serious, which is easy to become cancerous and seriously affects the quality of life of patients.
How to achieve standardized treatment of reflux esophagitis?
Acid inhibitors are the first-line drugs to treat reflux esophagitis, but the current acid inhibitors have limitations. Potassium ion competitive acid inhibitor is a new type of acid inhibitor, namely vorosone fumarate tablets, which was approved by National Medical Products Administration two years ago and officially entered China. The acid inhibition effect is more obvious. Traditional acid inhibitors can achieve the same effect after taking it for 8 weeks. This medicine can achieve the same effect as long as it is taken for 4 weeks. But also can better promote mucosal healing. Relevant clinical studies show that the healing rate of Votalin tablets in 4 weeks is 96.6%, which is higher than that of Lansoprazole in 8 weeks, and the healing rate of Votalin tablets in 8 weeks is as high as 99%, which can better meet the treatment standard of reflux esophagitis.
Tips: If you have symptoms of reflux esophagitis, you must go to a regular hospital as soon as possible and find a professional doctor for treatment. A long illness will not only aggravate the condition, but also cause a series of complications, causing greater harm.